Catheter Ablation of Brugada Syndrome: Importance of Repeated Administration of Ajmaline to Unmask the Entire Epicardial Substrate

JACC Clin Electrophysiol. 2017 Nov;3(11):1330-1332. doi: 10.1016/j.jacep.2017.02.014. Epub 2017 Apr 26.

Authors

Konstantin Krieger¹, Johannes Steinfurt², Corinna Lenz³, Boris Keweloh³

Affiliations

¹ Department of Internal Medicine and Cardiology, Unfallkrankenhaus Berlin, Berlin, Germany. Electronic address: konstantin.krieger@ukb.de.
² Department of Cardiology and Angiology I, Heart Center University of Freiburg, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
³ Department of Internal Medicine and Cardiology, Unfallkrankenhaus Berlin, Berlin, Germany.

PMID: 29759632
DOI: 10.1016/j.jacep.2017.02.014

No abstract available

Keywords: Brugada syndrome; ablation; ajmaline; epicardial mapping; ventricular fibrillation.

Publication types

Case Reports

MeSH terms

Ajmaline / administration & dosage*
Ajmaline / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Brugada Syndrome / diagnosis
Brugada Syndrome / therapy*
Catheter Ablation / adverse effects*
Catheter Ablation / methods
Defibrillators, Implantable
Epicardial Mapping / methods*
Humans
Male
Middle Aged
Tachycardia, Ventricular / diagnosis
Tachycardia, Ventricular / prevention & control
Tachycardia, Ventricular / therapy

Substances

Anti-Arrhythmia Agents
Ajmaline